PLX
Protalix BioTherapeutics, Inc.Company with tickers: PLX
CIK
1006281
CUSIP
74365A309
Shares Outstanding
80,571,642
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-12-19 | Bashan Dror | Director, PRESIDENT AND CEO | Other | 2,344,418 |
| 2025-12-19 | Bashan Dror | Director, PRESIDENT AND CEO | Buy | 56,000 |
| 2025-11-18 | Bar-Shalev Amos | Director | Sell | 168 |
| 2025-11-18 | Bar-Shalev Amos | Director | Other | 7,500 |
| 2025-09-03 | Naos Yaron | Sr. VP, Operations | Award | 50,000 |
| 2025-09-03 | Naos Yaron | Sr. VP, Operations | Award | 25,000 |
| 2025-09-03 | Naos Yaron | Sr. VP, Operations | Other | 7,112 |
| 2025-09-03 | Bar-Shalev Amos | Director | Award | 15,000 |
| 2025-09-03 | Bar-Shalev Amos | Director | Other | 168 |
| 2025-09-03 | Bashan Dror | Director, PRESIDENT AND CEO | Award | 195,000 |
| 2025-09-03 | Bashan Dror | Director, PRESIDENT AND CEO | Award | 340,000 |
| 2025-09-03 | Bashan Dror | Director, PRESIDENT AND CEO | Other | 132,516 |
| 2025-09-03 | Melincoff Gwen A | Director | Award | 7,500 |
| 2025-09-03 | Melincoff Gwen A | Director | Award | 15,000 |
| 2025-09-03 | Forster Eliot | Director | Award | 15,000 |
| 2025-09-03 | Forster Eliot | Director | Award | 7,500 |
| 2025-09-03 | Schwartz Aharon | Director | Other | 303,000 |
| 2025-09-03 | Schwartz Aharon | Director | Award | 7,500 |
| 2025-09-03 | Schwartz Aharon | Director | Award | 15,000 |
| 2025-09-03 | Elze Christian | Director | Award | 7,500 |
| 2025-09-03 | Elze Christian | Director | Award | 15,000 |
| 2025-09-03 | Bar-Shalev Amos | Director | Award | 7,500 |
| 2025-09-03 | Ben Zvi Shmuel | Director | Award | 15,000 |
| 2025-09-03 | Ben Zvi Shmuel | Director | Award | 7,500 |
| 2025-09-03 | Boudes Pol F | Director | Award | 15,000 |
| 2025-09-03 | Boudes Pol F | Director | Other | 40 |
| 2025-09-03 | Boudes Pol F | Director | Award | 7,500 |
| 2025-08-24 | Mamlok Gilad | Director | Other | 0 |
| 2025-06-26 | Elze Christian | Director | Other | 0 |
| 2025-06-10 | Schwartz Aharon | Director | Buy | 129,000 |
| 2024-09-23 | Naos Yaron | Sr. VP, Operations | Award | 100,000 |
| 2024-09-23 | Rubin Eyal | Chief Financial Officer | Award | 99,010 |
| 2024-04-01 | Bashan Dror | Director, PRESIDENT AND CEO | Award | 263,960 |
| 2023-10-19 | Bashan Dror | Director, PRESIDENT AND CEO | Buy | 16,129 |
| 2023-10-19 | Bashan Dror | Director, PRESIDENT AND CEO | Buy | 48,387 |
| 2023-09-29 | Ben Zvi Shmuel | Director | Award | 61,676 |
| 2023-09-29 | Bar-Shalev Amos | Director | Award | 61,676 |
| 2023-09-29 | Schwartz Aharon | Director | Award | 61,676 |
| 2023-09-29 | Boudes Pol F | Director | Award | 61,676 |
| 2023-09-29 | Melincoff Gwen A | Director | Award | 61,676 |
| 2023-09-14 | Forster Eliot | Director | Award | 85,715 |
| 2023-09-14 | Forster Eliot | Director | Other | 0 |
| 2023-08-15 | Hayon Yael | VP, Research & Development | Award | 35,115 |
| 2023-08-15 | Hayon Yael | VP, Research & Development | Award | 35,115 |
| 2023-08-15 | Naos Yaron | Sr. VP, Operations | Award | 187,344 |
| 2023-08-15 | Naos Yaron | Sr. VP, Operations | Other | 7,112 |
| 2023-08-15 | Rubin Eyal | Chief Financial Officer | Award | 201,903 |
| 2023-08-15 | Bashan Dror | Director, PRESIDENT AND CEO | Other | 68,000 |
| 2023-08-15 | Bashan Dror | Director, PRESIDENT AND CEO | Award | 800,000 |
| 2023-04-01 | Bashan Dror | Director, PRESIDENT AND CEO | Other | 132,516 |
| 2023-01-03 | Schwartz Aharon | Director | Buy | 110,000 |
| 2022-09-07 | Boudes Pol F | Director | Award | 50,000 |
| 2022-09-07 | Melincoff Gwen A | Director | Award | 50,000 |
| 2022-09-07 | Bar-Shalev Amos | Director | Award | 50,000 |
| 2022-09-07 | Schwartz Aharon | Director | Award | 50,000 |
| 2022-09-07 | Rubin Eyal | Chief Financial Officer | Award | 350,000 |
| 2022-09-07 | Hayon Yael | VP, Research & Development | Award | 250,000 |
| 2022-09-07 | Naos Yaron | Sr. VP, Operations | Award | 340,000 |
| 2022-09-07 | Ben Zvi Shmuel | Director | Award | 10,000 |
| 2022-09-07 | Bronfeld Zeev | Director | Award | 100,000 |
| 2022-09-07 | Bashan Dror | Director, PRESIDENT AND CEO | Award | 750,000 |
| 2022-06-30 | Ben Zvi Shmuel | Director | Other | 0 |
| 2022-06-30 | Ben Zvi Shmuel | Director | Award | 40,000 |
| 2022-04-11 | Bashan Dror | Director, PRESIDENT AND CEO | Buy | 68,000 |
| 2022-04-11 | Bashan Dror | Director, PRESIDENT AND CEO | Other | 1,085,458 |
| 2022-02-25 | Rubin Eyal | Chief Financial Officer | Award | 121,951 |
| 2022-02-25 | Bashan Dror | Director, PRESIDENT AND CEO | Award | 637,531 |
| 2021-06-03 | Dexcel Pharma Technologies Ltd. | 10% Owner | Sell | 857,506 |
| 2021-06-02 | Dexcel Pharma Technologies Ltd. | 10% Owner | Sell | 61,211 |
| 2021-02-12 | Dexcel Pharma Technologies Ltd. | 10% Owner | Other | 4,556,031 |
| 2021-02-12 | Dexcel Pharma Technologies Ltd. | 10% Owner | Other | 0 |
| 2020-08-11 | Bashan Dror | Director, PRESIDENT AND CEO | Award | 447,927 |
| 2020-08-11 | Naos Yaron | Sr. VP, Operations | Award | 122,656 |
| 2020-08-11 | Rubin Eyal | Chief Financial Officer | Award | 246,146 |
| 2020-07-05 | Hayon Yael | VP, Research & Development | Other | 0 |
| 2020-07-05 | Hayon Yael | VP, Research & Development | Award | 129,771 |
| 2020-06-07 | Almon Einat Brill | SVP, Chief Development Officer | Award | 196,995 |
| 2020-04-07 | Schwartz Aharon | Director | Buy | 64,000 |
| 2020-02-03 | Bronfeld Zeev | Director | Award | 240,000 |
| 2020-01-20 | Bar-Shalev Amos | Director | Award | 40,000 |
| 2020-01-20 | Melincoff Gwen A | Director | Award | 40,000 |
| 2020-01-20 | Boudes Pol F | Director | Award | 40,000 |
| 2020-01-20 | Granot David | Director | Award | 40,000 |
| 2020-01-20 | Schwartz Aharon | Director | Award | 40,000 |
| 2020-01-01 | Melincoff Gwen A | Director | Other | 0 |
| 2020-01-01 | Boudes Pol F | Director | Other | 40 |